<article>

<h1>How Market Research Insights Led to the Need for Diabetologist Unmet Patient Monitoring Device & Data Integration Support Survey | Ken Research</h1>

<p>
Healthcare businesses are entering 2025 and 2026 with a stronger focus on connected diabetes care, patient monitoring, and clinical data integration. The 2025 IDF Diabetes Atlas highlights that <strong>589 million adults aged 20–79 years are living with diabetes globally</strong>, equal to nearly <strong>1 in 9 adults</strong>. It also estimates diabetes-related health expenditure at around <strong>USD 1 trillion</strong>, showing how diabetes has become one of the most financially significant chronic disease areas for healthcare systems, payers, device manufacturers, and digital health companies.
</p>

<p>
In 2025, diabetes care is increasingly shaped by continuous glucose monitors, connected glucometers, insulin delivery devices, mobile health apps, remote monitoring platforms, and clinical dashboards. In 2026, diabetes technology expectations are expected to become even more integrated with patient care, as clinical guidance continues to emphasize glucose monitoring, insulin delivery, and digital tools. <strong>The key challenge is no longer only device availability; it is whether monitoring data can become timely, integrated, and clinically useful.</strong>
</p>

<p>
Through healthcare market research and clinical workflow analysis, several unmet gaps were identified. Diabetologists are managing higher patient volumes, more device-generated data, and growing pressure to improve glycemic outcomes. However, many monitoring systems still create fragmented reports, manual data reconciliation, multiple dashboards, and limited integration with electronic health records. These findings created the need for the <a href="https://www.kenresearch.com/survey/diabetologist-unmet-patient-monitoring-device-data-integration-support-survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>Diabetologist Unmet Patient Monitoring Device & Data Integration Support Survey</strong></a> by <a href="https://www.kenresearch.com/survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>Ken Research</strong></a>.
</p>

<h2>What Did Our Market Research Reveal About the Industry?</h2>

<p>
Market research shows that diabetes care is shifting from periodic consultation-based treatment to continuous, data-enabled disease management. Diabetologists now require faster access to glucose trends, clearer device reports, reliable patient monitoring tools, and better integration between monitoring systems and clinic workflows. Patients also expect easier device setup, mobile visibility, real-time alerts, affordability, and simple data sharing with doctors.
</p>

<p>
Despite this growth, many healthcare companies still struggle to understand why some monitoring devices achieve stronger doctor recommendation while others face weak adoption. A product may be clinically accurate but difficult to use in busy practice settings. Another device may have strong patient visibility but poor integration with clinic systems. <strong>This shows that diabetes monitoring success depends on both clinical performance and workflow fit.</strong>
</p>

<h2>Why Businesses Were Struggling to Identify These Gaps</h2>

<p>
Many medical device companies and digital health platforms track sales, device activation, app usage, training requests, and support tickets. However, these metrics do not fully explain why diabetologists hesitate to recommend a device or why patients stop using monitoring tools after initial adoption.
</p>

<p>
The real gaps often sit deeper inside the clinical journey. These include report complexity, weak EHR compatibility, patient affordability issues, alert fatigue, poor onboarding, limited technical assistance, and lack of clinic-ready summaries. Without a structured <a href="https://www.kenresearch.com/survey/diabetologist-unmet-patient-monitoring-device-data-integration-support-survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>patient monitoring workflow survey</strong></a>, companies depend too much on assumptions instead of evidence.
</p>

<h2>How These Market Insights Created the Need for the Survey</h2>

<p>
The 2025–2026 market findings made it clear that healthcare companies need deeper physician feedback intelligence. Businesses must understand how diabetologists evaluate usability, accuracy, data integration, reporting quality, affordability, patient adherence, and vendor support before scaling device strategy.
</p>

<p>
The <a href="https://www.kenresearch.com/survey/diabetologist-unmet-patient-monitoring-device-data-integration-support-survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>diabetologist device adoption research</strong></a> solution helps CGM manufacturers, insulin device companies, digital health platforms, chronic care providers, and payer planners identify where monitoring device adoption breaks down. <strong>It converts fragmented physician feedback into a structured decision framework for product strategy, clinical support, and go-to-market planning.</strong>
</p>

<h2>What Does the Survey Measure?</h2>

<p>
The survey measures satisfaction levels across device performance, usability, accuracy perception, patient comfort, reporting clarity, onboarding support, clinical education, technical assistance, and post-adoption service quality. It also captures the complete clinical journey, including device recommendation, patient onboarding, data capture, consultation preparation, report interpretation, therapy adjustment, and long-term adherence support.
</p>

<p>
It also evaluates operational efficiency by identifying workflow friction inside clinics. These issues may include multiple device portals, manual data reconciliation, delayed report access, incompatible EHR systems, excessive notifications, and unclear escalation support. <strong>For diabetologists, monitoring technology is valuable only when it reduces clinical uncertainty without increasing administrative burden.</strong>
</p>

<h2>Key Insights Businesses Can Uncover Through This Survey</h2>

<p>
The survey helps businesses uncover hidden adoption issues that are not visible through sales dashboards. A device may have strong awareness but weak recommendation because doctors find it expensive, hard to explain, poorly integrated, or unsuitable for certain patient groups.
</p>

<p>
It also identifies unmet support needs, including better patient onboarding, automated glucose summaries, reimbursement guidance, clinic staff training, caregiver visibility, and stronger technical support. Through the <a href="https://www.kenresearch.com/survey/diabetologist-unmet-patient-monitoring-device-data-integration-support-survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>diabetes device support gap survey</strong></a>, companies can understand what doctors need to recommend monitoring solutions more confidently.
</p>

<h2>How Survey Intelligence Helps Businesses Improve Decision-Making</h2>

<p>
Survey intelligence helps healthcare companies move from assumption-led decisions to evidence-led strategies. Product teams can improve device features, simplify report design, strengthen interoperability, and align roadmaps with clinical workflow needs. Commercial teams can refine positioning based on what diabetologists actually value.
</p>

<p>
Clinical support teams can also design better education programs for doctors, patients, caregivers, and clinic staff. If diabetologists report that patients struggle with sensor use, app setup, or report interpretation, companies can create more targeted support models. <strong>In 2025 and 2026, healthcare companies that understand physician workflow friction will be better positioned to scale connected diabetes care solutions.</strong>
</p>

<h2>Why Industry-Led Surveys Are Becoming Essential</h2>

<p>
Industry-led surveys are becoming essential because diabetes technology is evolving faster than traditional feedback systems. Devices, digital platforms, AI alerts, remote care models, and integrated dashboards are changing quickly. Businesses that do not continuously measure doctor expectations risk building advanced tools that remain clinically underused.
</p>

<p>
In the future, diabetes monitoring solutions will not be judged only by data capture. They will be judged by how effectively they support clinical decisions, reduce workflow burden, improve patient adherence, and strengthen long-term outcomes.
</p>

<h2>Conclusion</h2>

<p>
The <a href="https://www.kenresearch.com/survey/diabetologist-unmet-patient-monitoring-device-data-integration-support-survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>Diabetologist Unmet Patient Monitoring Device & Data Integration Support Survey</strong></a> converts healthcare market insights into measurable business action. It helps medical device companies, digital health platforms, chronic care providers, and diabetology teams identify adoption friction, improve data integration, and align product strategy with real clinical needs.
</p>

<p>
<strong>CTA:</strong> Businesses can work with <a href="https://www.kenresearch.com/survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>Ken Research</strong></a> to adopt a research-backed <a href="https://www.kenresearch.com/survey/diabetologist-unmet-patient-monitoring-device-data-integration-support-survey?utm_source=microblog&utm_medium=Referral&utm_campaign=Vishal+Survey"><strong>diabetes patient monitoring survey program</strong></a> that measures diabetologist expectations, identifies device adoption barriers, and supports stronger evidence-led healthcare growth strategies.
</p>

</article>